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Abstract The cytosolic lipid peroxidation product 4-hydroxynonenal (HNE) is rapidly metabolized in mitochondria isolated from rat kidney cortex. 
About 80% of HNE was degraded within 3 min of incubation. Main products of HNE which were identified in mitochondria were the hydroxyn- 
onenoic acid, the 1,Cdihydroxynonene and the glutathione-HNE-conjugate. Furthermore, formation of metabolites of the tricarboxylic acid cycle 
from HNE is suggested. The quantitative share of HNE binding to proteins was high with about 8% of total HNE consumption after 
3 min of incubation. Therefore, rapid degradation of HNE by mitochondria might be involved in an intracellular antioxidative defense system. 
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1. Introduction 
4-Hydroxynonenal is a major product formed by lipid perox- 
idation from omega-&polyunsaturated fatty acids as linoleic 
acid and arachidonic acid (for review see [ 11). This aldehyde is 
cytotoxic at high concentrations (in the range of 100 PM), 
disturbs cell proliferation at low concentrations and exhibits 
genotoxic effects [2,3]. Furthermore in the submicromolar 
range 4-hydroxynonenal is chemotactic [4] and stimulates phos- 
pholipase C [5]. 4-Hydroxynonenal is rapidly metabolized in 
eucariotic cells [69]. We studied the metabolism of 4-hy- 
droxynonenal in isolated mitochondria by tracerkinetic experi- 
ments to investigate the 4-hydroxynonenal detoxication and the 
formation of intermediates from this lipid peroxidation prod- 
uct. 
2. Materials and methods 
4-Hydroxynonenal, radioactively labeled 4-hydroxynonenal ([2-3H]- 
HNE; 68.2 mCi/mmol) and standards for TLC were obtained from 
Prof. H. Esterbauer, Graz. HNE was prepared from the corresponding 
diacetal. ADP and succinate were obtained from Boehringer 
Mannheim, Germany. TLC plates and other chemicals and biochemi- 
cals of analytical grade were purchased from Merck, Darmstadt, Ger- 
many. 
Male Wistar rats weighing 200-250 g were used. Mitochondria were 
prepared as described by Jung et al. [lo]. The mitochondria were finally 
resuspended in a solution of 210 mM mannitol, 70 mM sucrose, 1 mM 
Tris-HCl and 1 mM EDTA (pH 7.4). Protein was determined using the 
Biuret method [IO] after precipitation of protein with trichloroacetic 
acid. The incubation was carried out in a medium of 210 mM sucrose, 
10 mM KCI, 0.5 mM KH,PO,, 0.5 mM EDTA, 60 mM Tris-HC1 (pH 
7.4), 10 mM succinate and 1.5 mM ADP. The protein concentration in 
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high-performance liquid chromatography; TLC, thin-layer chromatog- 
raphy. 
the incubation medium was about 1.2 mg/ml. After preincubation of 
mitochondria at 25°C for 1 min the reaction was started by adding 
radiolabeled HNE to give a final concentration of 100 PM (specific 
radioactivity for incubation after mixing radioactive labeled HNE and 
unlabeled HNE was 1.92 mCi/mmol corresponding to 4272 dpm/nmol 
HNE). The total incubation time was 10 min and the incubation tem- 
perature was 25’C. After different incubation periods aliquots of the 
suspensions were taken. The HNE metabolizing reactions were stopped 
by the addition of 0.5 ml mitochondria suspension to an equal volume 
of acetonitrile/acetic a id mixture (96: 4; v/v). After centrifugation two 
aliquots of the supematant were eluted on TLC plates. The TLC- 
separation and identification of HNE metabolites was carried out as 
described previously by Grune et al. [I 11. The elution with hexanel 
diethylether (3 : 7; v/v) allowed the separation of 4-hydroxynonenal, 
4-hydroxynonenoic acid and 1,Cdihydroxynonene. The elution with 
butanol/acetic acid/water (4: 1: 1; v/v/v) allowed the determination of 
GSH-adducts of 4-hydroxynonenal. For quantification of HNE utiliza- 
tion rates the radiolabeled compounds were scanned by an automatic 
TLC linear analyzer (Berthold, Wildbach, Germany). The acetonitrilel 
acetic acid extracts were used for the determination of 4-hydroxy- 
nonenal and 4-hydroxynonenoic acid by an HPLC-method, too. The 
disappearance of 1 PM HNE was measured only by the HPLC-method 
(determination of remaining HNE during the whole experiment). The 
conditions were: (150 x 4.6 mm) C,* column, acetonitrile/water (4 : 6; 
v/v), 1 ml/min, 223 nm detection wavelength. The protein precipitate 
was washed with physiological saline solution, then dissolved in 100@ 
Protosol-Tissue and Gel Solubilizer (New England, Nuclear, Boston, 
USA) and added to 10 ml of toluene scintillation fluid (0.4% 2-(4’-butyl 
phenyl)-5-(4”-biphenyl)-1,3,4oxadiazol in toluene) and measured by 
means of a beta-counter (Berthold, Wildbad, Germany). 
In additional fractionation experiments after 10 min of incubation 
of mitochondrial suspension in presence of radioactive labeled HNE the 
reaction was stopped by addition of an ice cold digitonin solution 
(Merck, Darmstadt; 1.2 mg/lO mg mitochondrial protein) and the sus- 
pension was brought rapidly to the temperature of 4°C. The proteins 
of the outer membrane, of the inner membrane, of the intermembrane 
space and of the matrix were isolated according to the method described 
in [12]. 
3. Results 
First we measured the rate of catabolism of HNE within 10 
min of incubation after treatment with 100 PM HNE. From the 
decrease of the HNE concentration in the first 30 s (56.1 nmol/ 
mg protein) one can calculate the maximal HNE detoxification 
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rate of 112.2 nmol/mg proteinlmin. The degradation of HNE 
approaches a steady state after 3 min. This is more clearly 
observed by investigating the HNE disappearance rate after 
adding 1 ,uM HNE (Fig. 1). Fig. 1 gives the degradation of 
1 PM HNE. After 2 min of incubation, a steady state for the 
remaining HNE level has been adjusted to about 0.1 PM. HNE 
is metabolised by renal mitochondria to 4-hydroxynonenoic 
acid, 1 ,Cdihydroxynonene and the GSH-HNE-adduct (Table 
1). All of the three metabolites increased very rapidly within the 
first minutes. The HNE-GSH-adduct and the 4-hydroxyn- 
onenoic acid reached the maximum value after about 2 min, 
and thereafter these metabolites slowly decreased. Within the 
incubation time the concentration of 4-hydroxynonenoic acid 
increased. The sum of the three primary metabolites 
DHN+HNA+GSH-HNE is 25.2% of the total initial HNE 
concentration after 30 s and 22.6% after 3 min of incubation. 
After 3 min about 10% of the radioactivity used was found to 
be in the HNE-GSH pool and 8% of the radioactivity was 
bound to proteins. Table 2 includes the percentage of radioac- 
tivity which was measured in the different mitochondrial frac- 
tions and the values of nmol HNE bound per mg protein in 
these fractions. The protein bound radioactive HNE (about 6% 
of total radioactivity after 10 min of incubation) is found pre- 
dominantly bound to the proteins of the intermembrane space 
(5.25% of total radioactivity). Lesser amounts are found bound 
to the proteins of the inner membrane (0.28 %) and to the 
proteins of the matrix (0.18%). The nmol HNE per mg protein 
was found to be very high in the intermembrane space and 
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Fig. 1. HNE degradation i  mitochondria from rat kidney cortex after 
addition of 1 pmol/l HNE. The HNE concentration was determined 
by the HPLC-method, as described in section 2. Values are given as 
mean f SD. 
mitochondrial low-specific low K,,,-aldehyde dehydrogenase 
(EC 1.2.1.3) oxidizes HNE to 4-hydroxynonenoic acid. 4-Hy- 
droxynonenal was shown to be a substrate for oxidative metab- 
olism by mitochondrial aldehyde dehydrogenase isoenzymes 
u51. 
4. Discussion 
It could be demonstrated that the primary products (4-hy- 
droxynonenoic acid, 1,4_dihydroxynonene and HNE-GSH) are 
formed in mitochondria of rat kidney cortex after addition of 
HNE to the mitochondria suspension in state 3 respiration. The 
formation of hydroxynonenoic acid was also measured by 
HPLC (data consistant with the radioactive method). As sec- 
ondary products of HNE metabolism up to now GSH-DHN 
conjugate and water, which is generated through the beta- 
oxidation of 4-hydroxynonenoic acid could be identified in rat 
hepatocytes [7,13,14]. The water formation from the acid could 
be inhibited by 4-pentenoic acid as inhibitor of beta-oxidation 
of fatty acids, particularly an inhibitor of acyl CoA dehydroge- 
nase [13]. Our data suggest hat the primary formed l,Cdihy- 
droxynonene was metabolized by oxidation to 4-hydroxyn- 
onenoic acid, which can be subsequently degraded by 
betaoxidation and water formation. It can be assumed that the 
HNE reacts with sulfbydryl and amino groups of proteins. 
The share of the protein-HNE adducts formed was about 10% 
and decreased slowly to about 6% after 10 min. The results of 
fractionation experiments argue in support of the statement 
that the inner membrane acts like a barrier for the HNE pene- 
tration into the matrix. The HNE protein binding shows high 
values in the intermembrane space. Nevertheless, the protein 
binding in the inner membrane and in the matrix is high enough 
to suggest hat there exists a penetration of HNE via the inner 
membrane into the matrix. The protein binding in mitochon- 
dria is expected to be of great functional importance for mito- 
chondrial damage by HNE in situations of increased HNE 
formation. In Ehrlich mouse ascites cells the fraction of HNE 
binding to proteins was high in the proliferating phase (up to 
8%) and low in the resting phase of tumor growth (about 2% 
[14]. In hepatocytes the protein-HNE adducts amounts to 
about 3% of the total HNE. That was significantly lower than 
in our experiments with mitochondria. 
4-Hydroxynonenal reacts via Michael addition of a pH-de- 
pendent manner with glutathione producing a glutathione-4- 
hydroxynonenal conjugate molecule [ 161. The depletion of 
GSH by 4-hydroxynonenal in a variety of experimental cellular 
Table 1 
Concentration of HNE intermediates in rat mitochondrial suspensions from kidney cortex compared with those in hepatocyte suspensions [6,13] and 
in rat enterocyte suspensions [11,13] after the addition of 100 PM HNE 
Metabolite Mitochondria Hepatocytes Enterocytes 
Time 0.5 min 3 min 10 min 3 min 3 min 
1,4-Dihydroxynonene 14.6 + 2.6 9.3 + 1.8 1.1 f 0.9 8.1 f 2.1 5.4 f 0.6 
HNE-GSH-adduct 8.4 f 1.2 9.8 f 1.2 7.4 f 0.8 21.5 + 2.5 11.0 + 0.5 
4-Hydroxynonenoic acid 2.2 f 0.7 5.9 f 0.7 6.2 f 0.8 25.3 f 5.6 4.2 f 0.6 
HNE-modified proteins 10.0 f 1.5 8.4 f 1.4 5.8 f 0.9 3.0 f 0.6 1.3 t 0.2 
Incubations with hepatocytes and enterocytes were carried out at pH 7.4,37”C and with lo6 cells/ml suspension, with mitochondria at pH 7.4,25”C 
and with 1.2 mg protein/ml suspension. Values as nmoUm1 suspension which is equal to % of the initial HNE concentration (mean f S.D.). 
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Table 2 
Distribution of protein bound radioactivity within mitochondrial com- 
partiments after 10 min of treatment of isolated kidney cortex mito- 
chondria with 100 uM HNE 
% of total % of protein 





Outer membrane 0.02 f 0.002 0.35 0.53 
Intermembrane space 5.25 * 0.55 91.67 69.11 
Inner membrane 0.28 f 0.04 4.90 0.27 
Mitochondrial matrix 0.18 f 0.02 3.08 0.39 
[2] Poot, M., Verkerk, A., Koster, J.F., Esterbauer, H. and Jongkind, 
J.F. (1988) Mech. Ageing Dev. 43, l-9. 
[3] Eckl, P. and Esterbauer, H. (1989) Adv. Biosci. 76, 141-157. 
]4] Curzio, M. (1988) Free Rad. Res. Commun. 5, 55-66. 
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[6] Siems, W.G., Zollner, H. and Esterbauer, H. (1990) Free Rad. 
Biol. Med. 9, 110. 
Fragmentation of mitochondria was carried out according to [7] Esterbauer, H., Zollner, H. and Lang, J. (1985) Biochem. J. 228, 
Schnaitman [12]. Values represent he mean + S.D. (n = 4). 363-373. 
systems has been reported by many authors. Table 1 shows the 
concentration of HNE intermediates in hepatocyte [ 131, entero- 
cyte [l l] and mitochondrial suspensions. From a quantitative 
point of view, the main products of HNE in hepatocyte suspen- 
sion were the HNE-GSH conjugate and the 4-hydroxynonenoic 
acid. In mitochondrial suspension the enzymatic conversion of 
4-hydroxynonenal with GSH to the GSH-HNE adduct seems 
to be of minor importance. Until now no mitochondrial-spe- 
cific form of glutathione-S-transferase was described. Obvi- 
ously the relatively low formation rate of HNE-GSH conjugate 
is due only to the chemical reaction between HNE and GSH 
even at very high intramitochondrial GSH levels. The low con- 
centration of hydroxynonenoic acid suggests a high metabolic 
rate of this acid and low steady state concentration. 
The HNE catabolism is an important component of the anti- 
oxidative defense system of cells because of the cytotoxic effects 
of the secondary product of lipid peroxidation. Our data sug- 
gest that mitochondrial HNE metabolism as part of the whole 
intracellular HNE degradation also is very important for the 
antioxidative protection of cells. 
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